Commonly reported side effects (incidence 5%) include: nausea, diarrhea, constipation, vomiting, injection site reactions, headache, low blood sugar, heartburn, fatigue (sleepiness), dizziness, stomach-area pain, increased lipase (a pancreatic enzyme), upper stomach-area pain, fever, and stomach infection (gastroenteritis)
It will be the first GLP-1 tablet for weight loss when it becomes available
Restrictions for people below the drinking age (under 21 years old) Drivers under 21 years old have a BAC limit of 0.05% as per the VC 23140
We can refer back to the 2007 Pyo study for more insights, too
most likely by inducing oxidative stress
To further assess the ROS scavenging ability of G/D-CuP, the 2, 7-dichlorofluorescein diacetate (DCFH-DA) fluorescent probe was used to measure intracellular ROS levels